about
Update on diagnosis and monitoring of cystic fibrosis-related diabetes mellitus (CFRD)Determinants of intensive insulin therapeutic regimens in patients with type 1 diabetes: data from a nationwide multicenter survey in BrazilHealth-related quality of life in patients with type 1 diabetes mellitus in the different geographical regions of Brazil: data from the Brazilian Type 1 Diabetes Study GroupDyslipidemia in young patients with type 1 diabetes mellitus.Maturity-onset diabetes of the young (MODY) in Brazil: Establishment of a national registry and appraisal of available genetic and clinical data.Regional differences in clinical care among patients with type 1 diabetes in Brazil: Brazilian Type 1 Diabetes Study Group.Thyroid function and autoimmunity in children and adolescents with Type 1 Diabetes Mellitus.First two years' response to growth hormone treatment in very young preterm small for gestational age children.Mild adrenal insufficiency due to a NROB1 (DAX1) gene mutation in a boy presenting an association of hypogonadotropic hypogonadism, reduced final height and attention deficit disorder.Three unreported glucokinase (GCK) missense mutations detected in the screening of thirty-two Brazilian kindreds for GCK and HNF1A-MODY.A novel glucokinase deletion (p.Lys32del) and five previously described mutations co-segregate with the phenotype of mild familial hyperglycaemia (MODY2) in Brazilian families.[Management of diabetes mellitus in young children].Near-final height in patients with congenital adrenal hyperplasia treated with combined therapy using GH and GnRHa.Importance of screening with oral glucose tolerance test for early diagnosis of cystic fibrosis-related diabetes mellitus."KiDS and Diabetes in Schools" project: Experience with an international educational intervention among parents and school professionals.ISPAD Position Statement on Type 1 Diabetes in SchoolsISPAD Clinical Practice Consensus Guidelines 2018: Microvascular and macrovascular complications in children and adolescentsInsulin Injection Technique Questionnaire: results of an international study comparing Brazil, Latin America and World dataShort-acting insulin analogues versus regular human insulin on postprandial glucose and hypoglycemia in type 1 diabetes mellitus: a systematic review and meta-analysisHaptoglobin polymorphism and diabetic retinopathy in Brazilian patientsCholesterol oxides as biomarkers of oxidative stress in type 1 and type 2 diabetes mellitus[Growth hormone therapy and hypersensitivity type III reaction: a contraindication for desensitization]ISPAD Annual Conference 2017 HighlightsISPAD Clinical Practice Consensus Guidelines 2018: Management and support of children and adolescents with type 1 diabetes in schoolInfections in children with diabetesReal-world flash glucose monitoring in Brazil: can sensors make a difference in diabetes management in developing countries?Genomic ancestry and glycemic control in adolescents with type 1 diabetes. A multicenter study in Brazil
P50
Q26830633-52F96967-1F8A-46F5-B41C-28A6F2DC53DDQ30830573-9E8457F5-31EF-4034-B4CA-B742BC2671D7Q31003296-95627B25-EC42-4DE9-BF51-041428C8A0C5Q35685832-FF1830B2-7CBB-4F18-95E6-442985B52B19Q36232749-C690F315-2CC4-4B08-8ECA-571475125B08Q36513518-4A0B9B8F-5146-46F6-B419-6D808B72F024Q41518836-7BBF4C9B-E23E-4A6E-A973-80B4D9DF67A8Q43257996-CDE6166A-C324-45D1-AC87-FCDB42D08C01Q43726421-52DBE679-AA66-4AC5-A8D1-E57EF1C42740Q43802799-9FF5D016-6DC8-4743-B5CB-015D2B1A9073Q44241476-C2EC2B4B-3F57-4704-8FD4-54B60C93106EQ46625445-2E62CDC0-ACAA-42F5-9420-9616E3882E42Q47334146-EF67941D-E339-418F-A950-F0815BBF0103Q50751448-AF8C3864-4D69-4092-868A-FCFCD5A42EEBQ52674657-CB3455FB-FBB7-453B-9441-2E64657CF2B4Q57181241-6A094F74-183D-4EB1-ADE7-9D4CE7234C0AQ57928387-3652068E-929B-4A23-BFA3-48D9ED31CB1FQ59332878-ED62B1B1-BD19-4F24-A0DA-FC0F9BD979BCQ60921475-7989B423-73D1-4265-9C03-9B27BFDFED68Q79715130-5FC4D9E1-A03B-4538-B168-7C2D80A17605Q83192311-77790F2F-AB82-4389-9299-1411C35E86DDQ83789187-3EC7ECDF-064D-45FF-92D6-C3B82C20DECAQ89398215-4FCB288C-616D-46C0-8DA6-01B61A1A7E0AQ90801602-06CA327A-7888-4883-B298-810CA1019227Q91010137-83425F6C-EE66-4C5D-80A3-0DA0C64705B8Q92539950-075ACF2C-B621-411E-B4E3-7B3BCD5CBC6EQ93234417-6004B9F7-0E22-4063-AFC9-7007E5408B3C
P50
description
researcher ORCID ID = 0000-0003-2085-5316
@en
wetenschapper
@nl
name
Luis Eduardo Calliari
@ast
Luis Eduardo Calliari
@en
Luis Eduardo Calliari
@es
Luis Eduardo Calliari
@nl
type
label
Luis Eduardo Calliari
@ast
Luis Eduardo Calliari
@en
Luis Eduardo Calliari
@es
Luis Eduardo Calliari
@nl
prefLabel
Luis Eduardo Calliari
@ast
Luis Eduardo Calliari
@en
Luis Eduardo Calliari
@es
Luis Eduardo Calliari
@nl
P1153
7003862299
P21
P31
P496
0000-0003-2085-5316